Datasheet | May 12, 2021

Innovative Drug-Eluting Implants

Source: Celanese
VitaldoseEVA

Vitaldose® EVA is an enabling technology formulators can leverage to create effective implants for long-acting controlled release therapeutics.

Ease of Formulation:

  • Vitaldose® EVA is a platform compatible with biologics, peptides, and small molecules.
  • Many implant designs are possible ranging from single phase to co-continuous structures. Monolithic as well as multilayer constructions are possible.
  • Furthermore, formulators have the flexibility to incorporate additional inactive ingredients required for a particular design.
  • Vitaldose® EVA is compatible with various manufacturing platforms including micronization, blending, hot melt extrusion, injection molding, and spray dispersions.
VIEW THE DATASHEET!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma